XML 120 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders Equity - Restricted stock unit (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
EquityInstruments
Dec. 31, 2021
USD ($)
EquityInstruments
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 98,894  
Number of other equity instruments outstanding in share-based payment arrangement at end of period 102,104 98,894
Restricted Share Units    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 98,894 102,708
Granted 53,129 54,643
Settled (49,919) (58,457)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 102,104 98,894
Fair value of RSUs granted | $ $ 7.9 $ 7.2
Stock-based compensation expenses | $ 6.4 6.3
Capitalised to royalty, stream and working interest | $ 0.2 0.2
Total unrecognized non-cash stock-based compensation expense | $ $ 9.4 $ 8.7
Expected to be recognized over weighted average period 2 years 2 months 12 days 2 years 2 months 12 days
Performance based RSU    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 66,794 66,996
Granted 37,486 38,803
Settled (33,229) (39,005)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 71,051 66,794
Time-based RSU    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 32,100 35,712
Granted 15,643 15,840
Settled (16,690) (19,452)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 31,053 32,100